The complete GLP-1 support system
Medication is 20% of the equation. Monitoring, nutrition, muscle preservation, and protocol optimisation are the other 80%.
Most people start GLP-1 therapy with no baseline data
Which means they have no way to measure what changed, detect what went wrong, or prove what worked.
No pre-treatment metabolic snapshot
Without a baseline panel, there's no reference point. Improvements in HbA1c, HOMA-IR, or LDL-P go unmeasured — and so do adverse changes.
Muscle loss goes undetected
GLP-1 therapy accelerates lean mass reduction, not just fat. Without body composition monitoring, patients may lose muscle while the scale moves favourably.
Nutritional deficiencies compound
B12, D3, and zinc depletion are documented at 8 weeks in calorie-restricted GLP-1 patients. Most programmes do not check these markers.
The WellSpry GLP-1 Protocol
Structured across three phases of your treatment timeline.
- →Baseline panel — 72 biomarkers
- →DEXA or body composition estimate
- →Nutrition optimisation protocol
- →Quarterly monitoring panels
- →Muscle preservation protocol
- →Supplement guidance (B12, D3, zinc)
- →Outcomes data with baseline deltas
- →Dose optimisation evidence
- →Physician review for continuation/taper
From the WellSpry library
Blood Tests Before Starting GLP-1
The 12 markers your physician should order before your first dose — and why each one matters.
GLP-1 Muscle Loss Prevention Guide
Resistance training, protein targets, and supplement protocol to protect lean mass during GLP-1 therapy.
GLP-1 Nausea & B12 Supplements
Why B12 depletion drives nausea on GLP-1 therapy, and the supplementation protocol that addresses it.
GLP-1 medications can cost $900–$1,400/month without support
Our eligibility engine has helped members save an average of $340/month on their GLP-1 prescription.
Check your eligibility